Clinical Trial Update: Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations [Phase 2]

View source ↗

Summary

Phase 2 safety trial evaluating acamprosate for alcohol use disorder in post liver transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: University of Southern California | Conditions: Alcohol Use Disorder, Liver Transplant; Complications | Phase 2 | Status: COMPLETED